ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Biocon chief bats for dual-agency model to fast-track drug approvals
Biocon's Kiran Mazumdar-Shaw suggests a new drug approval system. The Indian Council of Medical Research would handle scientific reviews for new drugs and devices. The Central Drugs Standard Control Organisation would then grant final regulatory approval.
Announcement as on 23 November 2025

Biocon in very unique position globally as a biosimilars leader: Kiran Mazumdar-Shaw
Biocon is entering a transformative phase, leveraging regulatory shifts in the US and a strong insulin and GLP-1 portfolio to accelerate growth in the biologics space. The company is uniquely positioned with interchangeable biosimilar insulins and aims to
Announcement as on 21 November 2025

Biocon considers merging Biocon Biologics in .5 billion deal; IPO and share swap options under review
Biocon is exploring merging its biosimilars arm, Biocon Biologics, with itself, potentially valuing the unit at .5 billion. The company is in advanced talks with minority investors for a share swap, considering various value creation options including an
Announcement as on 13 November 2025

Biocon Q2 Results: Profit soars 428% YoY to Rs 85 crore on strong biosimilar and generics growth
Biocon Group reported a strong Q2 FY26 with a 20% year-on-year increase in operating revenue to Rs 4,296 crore, driven by biosimilars and generics. Net profit surged 428% to Rs 85 crore, boosted by debt settlement and strategic partnerships for affordable
Announcement as on 11 November 2025

Biocon unit gets USFDA nod for genetic anti-bacterial drug
Biocon's unit, in partnership with Carnegie Pharmaceuticals, has secured tentative approval from the USFDA for Rifaximin Tablets. This genetic anti-bacterial medication is used to reduce the risk of hepatic encephalopathy recurrence and treat irritable bow
Announcement as on 07 October 2025

Announcements by Biocon Ltd. first page | Next page | Prev page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 371.46
  • 12Day Average: 376.3
  • 20Day Average: 382.78
  • 50Day Average: 391.43
  • 100Day Average: 376.02
  • 150Day Average: 374.08
  • 200Day Average: 364

532523 Indicators & signals

Indicator MACD (12,26,9)

376.12, 381.64, -3.91
Indicator MACD is in negative zone

Indicator ADX (14)

32.28, 13.2, 25.79
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 44
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Thu Jan 2026 372.65 366.05 to 374.15 2.22% 0.21 times
21 Wed Jan 2026 364.55 359.05 to 370.00 -0.55% 0.66 times
20 Tue Jan 2026 366.55 365.50 to 375.55 -2.51% 0.95 times
19 Mon Jan 2026 376.00 373.00 to 378.20 -0.41% 0.26 times
16 Fri Jan 2026 377.55 374.80 to 385.25 -0.4% 0.49 times
14 Wed Jan 2026 379.05 372.90 to 383.70 0.46% 4.73 times
13 Tue Jan 2026 377.30 369.60 to 383.45 1.41% 1.13 times
12 Mon Jan 2026 372.05 366.25 to 380.80 -2% 0.42 times
09 Fri Jan 2026 379.65 372.15 to 384.35 0.45% 0.63 times
08 Thu Jan 2026 377.95 376.25 to 388.30 -2.39% 0.35 times
07 Wed Jan 2026 387.20 386.65 to 393.20 0.56% 0.39 times
06 Tue Jan 2026 385.05 383.10 to 394.30 -1.57% 0.3 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top